Dr. Jeffrey Wigle cloned and characterized a novel family of membrane proteins in his PhD work. During his postdoctoral fellowship, he determined that a gene, Prox1, was essential for the development of the lymphatic vessels in a mouse model. His current interests are in the transcriptional control of the process of cardiac fibrosis.
- Postdoctoral fellowship, St. Jude Children’s Research Hospital, Memphis, Tennessee
- PhD, department of pharmacology, University of Ottawa
- Bachelor of Science (Honours), department of biochemistry, Queen’s University
- Canadian Institutes of Health Research New Investigator Award
- Research Manitoba Chair
Visit Jeffrey Wigle's ORCID profile for a complete listing.
Jeffrey Wigle's profile